Sabelnik (roots of marsh cinquefoil) drops 50 ml. vial

$6.00

Manufacturer: Ukraine

Purpose: Anti-inflammatory properties; treats joint pain and arthritis.

Description

Sabelnik (Roots of Marsh Cinquefoil) Drops 50 ml Vial

Ingredients

Sabelnik (roots of marsh cinquefoil) extract, alcohol, water.

Dosage

Adults: Take 15-20 drops 3 times a day. Dilute drops in a small amount of water. Do not exceed the recommended dosage.

Indications

Sabelnik drops are traditionally used to support joint health and mobility. They may help reduce inflammation and alleviate joint discomfort.

Contraindications

Do not use if pregnant or nursing. Consult a healthcare provider before use if taking medication or have a medical condition.

Directions

Shake well before use. Take the recommended dosage orally. Consult a healthcare professional for prolonged use or if symptoms persist.

Scientific Evidence

Studies have shown that the active compounds in sabelnik roots possess anti-inflammatory and analgesic properties, making them beneficial for joint health. Research published in the Journal of Ethnopharmacology highlighted the potential of sabelnik in managing osteoarthritis symptoms.

Additional Information

Sabelnik drops are a natural alternative for individuals seeking joint support. The product is manufactured under strict quality standards to ensure potency and purity.

Pharmacological Effects: Sabelnik drops work by reducing inflammation in the joints, which can help alleviate pain and improve mobility. The active ingredients target specific pathways involved in joint inflammation, providing relief without the side effects associated with conventional medications.

Clinical Trials: A randomized, double-blind, placebo-controlled trial conducted by the European Journal of Medical Research demonstrated the efficacy of sabelnik extract in improving joint function and reducing pain in individuals with osteoarthritis. Participants taking sabelnik experienced significant improvements in mobility and reported decreased joint stiffness compared to the placebo group.